Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Stemcell Holdings Shareholders Equity (Quarterly): 6.009M for Sept. 30, 2018
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 6.009M |
| June 30, 2018 | 5.135M |
| March 31, 2018 | 4.845M |
| December 31, 2017 | 3.808M |
| September 30, 2017 | 3.080M |
| Date | Value |
|---|---|
| June 30, 2017 | 2.694M |
| March 31, 2017 | 1.842M |
| December 31, 2016 | 1.361M |
| September 30, 2016 | 1.175M |
| June 30, 2016 | 0.2096M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.23M |
| Perspective Therapeutics Inc | 75.18M |
| Protalix BioTherapeutics Inc | 33.57M |
| Electromed Inc | 40.34M |
| Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.03M |
| Total Liabilities (Quarterly) | 6.023M |